Showing results (31-40 of 120) with videos related to
Sort By:
Pageof 12
Transplantation|March 20, 2013
Clinically significant peripancreatic fluid collections after simultaneous pancreas-kidney transplantationRajinder Pal Singh, Georgios Vrakas, Samiha Hayek, et al.Journal of the American College of Surgeons|September 14, 2022
Crisis Preparedness: A Systems-Based Framework for Avoiding Harm in SurgeryPetrut Gogalniceanu, Nikolaos Karydis, Victor-Vlad Costan, et al.Nephron. Clinical Practice|March 26, 2014
UK Renal Registry 16th annual report: chapter 4 demography of patients waitlisted for renal transplantation in the UK: national and centre-specific analysesRishi Pruthi, Rachel Hilton, Laura Pankhurst, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 30, 2010
High anti-A titres may not preclude ABO-incompatible renal transplantation: an autoantibody could be the culpritNicholas Barnett, Anne Nightingale, Tim Maggs, et al.Annals of Surgery|January 10, 2024
How Does Surgeons' Autonomic Physiology Vary Intraoperatively?: A Real-time Study of Cardiac ReactivityKareena Del Rosario, Tessa V West, Wendy Berry Mendes, et al.Transplantation|June 11, 2010
Challenges facing renal transplantation in pediatric patients with lower urinary tract dysfunctionPaul Riley, Stephen D Marks, Divyesh Y Desai, et al.Kidney International|April 28, 2022
The phenotype of HLA-binding B cells from sensitized kidney transplant recipients correlates with clinically prognostic patterns of interferon-γ production against purified HLA proteinsHannah Burton, Laura McLaughlin, Kin Yee Shiu, et al.Journal of Vascular Surgery|January 11, 2011
Vascular access for hemodialysis in the elderlyNicola Swindlehurst, Andrew Swindlehurst, Heather Lumgair, et al.Clinical Transplantation|March 23, 2013
The use of eculizumab in renal transplantationA Nicholas R Barnett, Elham Asgari, Paramit Chowdhury, et al.Transplantation|June 24, 2010
Intermittent antibody-based combination therapy removes alloantibodies and achieves indefinite heart transplant survival in presensitized recipientsHina Shariff, Yakup Tanriver, Kathryn L Brown, et al.Pageof 12